 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              Mr. Arjun Handa - Managing Director & CEO, Claris Lifesciences
There is a lot of expectation from the Modi government, but it would be prudent not to expect overnight positives, the budget should be a strong budget with minimal populist measures, drawing the road map; for the next 5-10 years; of reduction in inflation and increase in Investments along with FDI. The key expectations in the near term are implementation of GST, revival of the investment cycle and stabilising the rupee.
Shares of CLARIS LIFESCIENCES LTD. was last trading in BSE at Rs.163.2 as compared to the previous close of Rs. 168.75. The total number of shares traded during the day was 131806 in over 2851 trades.
The stock hit an intraday high of Rs. 171.3 and intraday low of 160. The net turnover during the day was Rs. 21968575.